menu search

Nano one materials successfully completes phase two of co-development project with cbmm

Nano One Materials Corp (TSX:NANO, OTC:NNOMF) said phase two of the advanced lithium-ion battery cath...

May 17, 2023, 8:16 am

Tscan therapeutics presents preliminary phase 1 clinical results on tsc-100 and tsc-101 at the american society of gene & cell therapy 26th annual meeting

Poster highlights phase 1 results following treatment with TSC-100 and TSC-101 after hematopoietic cell...

May 17, 2023, 7:00 am

3 penny stocks primed to be 10-baggers in 5 years

In the entire history of financial markets, equities have never failed to make a strong comeback after a disappointing phase. Be it the Great Depressi...

May 17, 2023, 6:35 am

Oxford cannabinoid rise continues as first clincial trial gets started

Oxford Cannabinoid rose again as its confirmed recruitment for a phase 1 trial of its lead pain relief ...

May 17, 2023, 3:58 am

Oxford cannabinoid to start phase 1 trial for pain relief drug

Oxford Cannabinoid Technologies has received approval for a phase 1 trial in the UK of its lead pain r...

May 17, 2023, 2:45 am

Audusd analysis – may 17, 2023

The AUDUSD pair has been moving within a relatively tight range, oscillating between 0.6635 and 0.6709. This consolidation ...

May 17, 2023, 1:41 am

Enphase: fortune favors the brave now

Enphase Energy investors endured a 26% drop in its stock price after releasing weak Q2 guidance, wiping...

May 16, 2023, 12:00 pm

Nftfi launches earn season 1: promoting responsible nft lending

NFTfi, a leading NFT lending platform, has launched the next phase of its loyalty program NFTfi Rewards...

May 16, 2023, 8:09 am

Gold seen in consolidation phase

Gold is bullish on higher time frame charts where we expect a break to new ATH high, but ideally, this will occur after the current complex correction...

May 16, 2023, 7:10 am

Audusd analysis – may 16, 2023

The AUDUSD pair has been entrenched in a downtrend since its peak at 0.6817, with the recent bounce from 0.6635 being viewed as a corrective consolida...

May 16, 2023, 3:38 am

Perspective therapeutics reports first quarter fiscal 2023 results

Additional CDMO capabilities added to increase availability of clinical trial product in the US phase I...

May 16, 2023, 12:22 am

Bellerophon provides clinical program update and reports first quarter 2023 financial results

Last Patient Completed Blinded Treatment in REBUILD phase 3 Trial for INOpulse®; Pivotal Top-line Data...

May 15, 2023, 8:50 pm

Tesla: revisiting my 13 reasons to be cautious

Tesla, Inc. is in a strange position of a $500 billion empire finding itself in the growing pain phase. Tesla stock has fallen about 14% since my last...

May 15, 2023, 3:17 pm

Terns pharmaceuticals reports first quarter 2023 financial results and corporate updates

– Top-line data from phase 2a DUET clinical trial of TERN-501 (THR-β agonist) in NASH expected in th...

May 15, 2023, 12:05 pm

Pds biotech provides business update and reports first quarter 2023 financial results

Updated data from VERSATILE-002 phase 2 trial to be presented at ASCO 2023 Company to host conference c...

May 15, 2023, 11:30 am

Bridgebio pharma to present updated data from its bbp-812 canavan disease gene therapy program at the 2023 american society of gene and cell therapy (asgct) annual meeting

PALO ALTO, Calif., May 15, 2023 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage ...

May 15, 2023, 11:30 am

S&p 500 bear market: the smartest investors are buying these 3 beaten-down stocks

Despite Enphase Energy's recent setbacks, its fundamentals remain solid. 3M is in the bargain-bin with ...

May 15, 2023, 9:53 am

Us 500 index extends sideways move

The US 500 stock index (cash) has been gaining ground since mid-March, slicing through both its 50 and 200-day simple moving averages (SMAs). Neverthe...

May 15, 2023, 8:49 am

Bridgebio pharma to present updated data from its bbp-812 canavan disease gene therapy program at the 2023 american society of gene and cell therapy (asgct) annual meeting

PALO ALTO, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage ...

May 15, 2023, 7:30 am

Ecb de guindos indicates final phase of monetary policy tightening

In an interview with Il Sole 24 Ore, ECB Vice President Luis de Guindos highlighted the central bank’s shift towards a more conventional monetary po...

May 15, 2023, 3:12 am


Search within

Pages Search Results: